Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 11.48%75.11B | 12.77%67.38B | 18.98%17.12B | 10.07%17.36B | 8.71%16.53B | 13.78%16.36B | 12.66%59.75B | -1.63%14.39B | 18.91%15.78B | 21.01%15.21B |
| Cost of revenue | 10.39%65.55B | 11.86%59.38B | 17.51%15.12B | 9.56%15.14B | 8.15%14.61B | 12.58%14.51B | 13.83%53.08B | -1.21%12.87B | 19.02%13.81B | 22.51%13.51B |
| Gross profit | 19.49%9.56B | 19.97%8B | 31.64%2B | 13.61%2.23B | 13.14%1.92B | 24.20%1.85B | 4.15%6.67B | -5.18%1.52B | 18.19%1.96B | 10.34%1.7B |
| Operating expense | 12.85%6.04B | 29.56%5.36B | 28.09%1.46B | 19.90%1.25B | 38.31%1.33B | 32.90%1.33B | 18.38%4.13B | 27.55%1.14B | 21.92%1.04B | 12.05%958M |
| Staff costs | 13.56%2.95B | 32.18%2.6B | 41.33%701M | 27.33%629M | 28.89%638M | 31.11%628M | 16.35%1.96B | 9.25%496M | 19.90%494M | 20.15%495M |
| Selling and administrative expenses | 11.70%630M | 21.03%564M | 12.40%136M | 23.89%140M | 28.95%147M | 19.49%141M | 1.97%466M | 10.00%121M | 2.73%113M | 0.00%114M |
| -General and administrative expense | 11.70%630M | 21.03%564M | 12.40%136M | 23.89%140M | 28.95%147M | 19.49%141M | 1.97%466M | 10.00%121M | 2.73%113M | 0.00%114M |
| Depreciation and amortization | -12.50%420M | 152.63%480M | 252.38%222M | -67.44%14M | 285.71%162M | 95.24%82M | 3.26%190M | 23.53%63M | 0.00%43M | -6.67%42M |
| -Depreciation | -12.50%420M | 152.63%480M | 252.38%222M | -67.44%14M | 285.71%162M | 95.24%82M | 3.26%190M | 23.53%63M | 0.00%43M | -6.67%42M |
| Other operating expenses | 19.23%2.05B | 13.34%1.72B | -12.85%400M | 18.97%464M | 23.13%378M | 32.40%474M | 30.18%1.51B | 65.11%459M | 35.42%390M | 8.10%307M |
| Operating profit | 32.94%3.52B | 4.34%2.65B | 42.26%542M | 6.51%982M | -19.49%595M | 6.67%528M | -12.91%2.54B | -46.34%381M | 14.25%922M | 8.20%739M |
| Net non-operating interest income (expenses) | -0.23%-859M | -41.19%-857M | -46.85%-210M | -88.31%-290M | -26.92%-198M | -3.25%-159M | -16.51%-607M | 46.44%-143M | -85.54%-154M | -83.53%-156M |
| Non-operating interest income | 196.43%83M | 600.00%28M | 500.00%12M | 600.00%7M | 800.00%9M | --0 | -55.56%4M | 100.00%2M | -85.71%1M | 0.00%1M |
| Non-operating interest expense | 11.74%942M | 37.97%843M | 105.99%344M | 28.57%189M | 5.33%158M | 3.40%152M | 15.28%611M | -37.69%167M | 63.33%147M | 74.42%150M |
| Total other finance cost | ---- | --42M | ---122M | 1,250.00%108M | 600.00%49M | 0.00%7M | ---- | ---- | --8M | --7M |
| Net investment income | 7.63%2.13B | 16.42%1.98B | 21.40%817M | 188.75%142M | -3.45%727M | -32.56%292M | 17.33%1.7B | 10.51%673M | -222.14%-160M | 33.99%753M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -750.00%-13M | 2M | 0 | |||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -47.71%-678M | -88.89%-459M | -92.31%-375M | -68.75%-27M | -226.09%-75M | 300.00%18M | -442.25%-243M | -156.58%-195M | -107.14%-16M | 39.47%-23M |
| Less:Other special charges | 47.71%678M | 88.89%459M | 92.31%375M | 68.75%27M | 226.09%75M | -300.00%-18M | 50.93%243M | 156.58%195M | 100.00%16M | -39.47%23M |
| Other non-operating income (expenses) | 2.13%192M | 23.68%188M | 550.00%26M | -24.27%78M | 25.00%20M | 120.69%64M | -24.38%152M | -95.92%4M | 134.09%103M | -55.56%16M |
| Income before tax | 22.54%4.28B | -1.08%3.5B | 11.67%804M | 27.22%888M | -19.62%1.07B | -6.57%739M | -13.38%3.53B | -32.71%720M | -37.73%698M | 16.74%1.33B |
| Income tax | 22.53%1.44B | -5.33%1.17B | -33.66%205M | 34.50%347M | -15.44%345M | 4.56%275M | 5.90%1.24B | 9.96%309M | -10.42%258M | 15.91%408M |
| Net income | 22.50%2.85B | 1.26%2.32B | 46.10%599M | 22.95%541M | -21.57%720M | -11.95%464M | -21.13%2.3B | -47.97%410M | -47.24%440M | 17.39%918M |
| Net income continuous operations | 22.55%2.85B | 1.22%2.32B | 45.74%599M | 22.95%541M | -21.48%720M | -12.12%464M | -21.13%2.3B | -47.91%411M | -47.18%440M | 17.11%917M |
| Noncontrolling interests | 158.82%44M | -65.31%17M | -300.00%-4M | -7.14%13M | -65.22%8M | 0 | 36.11%49M | -111.11%-1M | 55.56%14M | 130.00%23M |
| Net income attributable to the company | 21.51%2.8B | 2.72%2.31B | 46.47%602M | 24.24%528M | -20.45%712M | -9.73%464M | -21.86%2.25B | -47.24%411M | -48.42%425M | 15.78%895M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 21.51%2.8B | 2.72%2.31B | 46.47%602M | 24.24%528M | -20.45%712M | -9.73%464M | -21.86%2.25B | -47.24%411M | -48.42%425M | 15.78%895M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 21.51%96.76 | 2.70%79.63 | 46.54%20.78 | 23.93%18.23 | -20.36%24.6 | -9.80%16.02 | -21.87%77.54 | -47.33%14.18 | -48.30%14.71 | 15.78%30.89 |
| Diluted earnings per share | 21.51%96.76 | 2.70%79.63 | 46.54%20.78 | 24.21%18.2295 | -20.42%24.5821 | -9.80%16.02 | -21.87%77.54 | -47.29%14.18 | -48.41%14.6761 | 15.78%30.89 |
| Dividend per share | 25.00%35 | 7.69%28 | 7.41%14.5 | 0 | 8.00%13.5 | 0 | 4.00%26 | 3.85%13.5 | 0 | 4.17%12.5 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |